<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:prn="http://www.prnewswire.com/ns/0.1/#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><link>https://www.prnewswire.com/rss/health-latest-news/medical-equipment-list.rss</link><atom:link rel="self" href="https://www.prnewswire.com/rss/health-latest-news/medical-equipment-list.rss" type="application/rss+xml"/><title>Medical Equipment</title><description>This category contains releases covering the medical equipment and technology sector. Read stories regarding research, development, testing, and marketing of new medical devices. Also included are study results, news about the FDA approval process, long term follow-up data, and information on medical breakthroughs and the release of new products. Find announcements of board changes, policy decisions, and company performance, including awards won, new partnerships, financial reports, and market analysis.</description><language>en-us</language><pubDate>Thu, 29 Oct 2026 05:33:47 +0000</pubDate><lastBuildDate>Wed, 28 Oct 2026 21:38:00 +0000</lastBuildDate><item><title>WHEN SOMEONE YOU KNOW IS DIAGNOSED WITH BREAST CANCER, KNOWING HER RADIATION OPTIONS CAN MAKE A DIFFERENCE</title><link>https://www.prnewswire.com/news-releases/when-someone-you-know-is-diagnosed-with-breast-cancer-knowing-her-radiation-options-can-make-a-difference-302922773.html</link><guid>https://www.prnewswire.com/news-releases/when-someone-you-know-is-diagnosed-with-breast-cancer-knowing-her-radiation-options-can-make-a-difference-302922773.html</guid><pubDate>Wed, 28 Oct 2026 21:38:00 +0000</pubDate><description><![CDATA[<p>SOMERSET, N.J., Oct. 28, 2026 /PRNewswire/ -- Most people know to encourage the women in their lives to stay current with breast cancer screening. But when a friend, partner, mother or colleague is diagnosed, a different question often follows: What treatment options should she ask about?...</p>]]></description><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:subject><![CDATA[Clinical Trials & Medical Discoveries]]></prn:subject><prn:subject><![CDATA[Women ]]></prn:subject><prn:subject><![CDATA[Diversity, Equity & Inclusion]]></prn:subject><dc:subject><![CDATA[WOM]]></dc:subject><dc:subject><![CDATA[TRI]]></dc:subject><dc:subject><![CDATA[DEI]]></dc:subject><dc:contributor><![CDATA[ProCure Proton Therapy Center]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Artivion to Participate in Upcoming Investor Conferences</title><link>https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302922646.html</link><guid>https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302922646.html</guid><pubDate>Wed, 28 Oct 2026 20:10:00 +0000</pubDate><description><![CDATA[<p>ATLANTA, Oct. 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. Artivion's management team will present at the upcoming Stifel 2026...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS600734/Artivion-new-Logo.jpg?id=OA3044866&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302922646.html'><img src='https://mmx.prnewswire.com/media/MS600734/Artivion-new-Logo.jpg?id=OA3044866&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:subject><![CDATA[Trade Show News ]]></prn:subject><dc:subject><![CDATA[FVT]]></dc:subject><dc:subject><![CDATA[TDS]]></dc:subject><dc:contributor><![CDATA[Artivion, Inc.]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>SetPoint Medical Announces First SetPoint® System Procedure in Boston at Beth Israel Deaconess Medical Center</title><link>https://www.prnewswire.com/news-releases/setpoint-medical-announces-first-setpoint-system-procedure-in-boston-at-beth-israel-deaconess-medical-center-302921794.html</link><guid>https://www.prnewswire.com/news-releases/setpoint-medical-announces-first-setpoint-system-procedure-in-boston-at-beth-israel-deaconess-medical-center-302921794.html</guid><pubDate>Wed, 28 Oct 2026 20:00:00 +0000</pubDate><description><![CDATA[<p>Only FDA-approved neuroimmune modulation therapy for rheumatoid arthritis is now available to adults throughout New England. SANTA CLARITA, Calif., Oct. 28, 2026 /PRNewswire/ -- SetPoint® Medical, a commercial-stage medical technology company dedicated to improving care for people living...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS1805341/SetPointMedical-Logo.jpg?id=OA3042969&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/setpoint-medical-announces-first-setpoint-system-procedure-in-boston-at-beth-israel-deaconess-medical-center-302921794.html'><img src='https://mmx.prnewswire.com/media/MS1805341/SetPointMedical-Logo.jpg?id=OA3042969&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Biotechnology]]></prn:industry><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:industry><![CDATA[BIO]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:subject><![CDATA[New Products & Services ]]></prn:subject><prn:subject><![CDATA[Clinical Trials & Medical Discoveries]]></prn:subject><prn:subject><![CDATA[FDA Approval]]></prn:subject><dc:subject><![CDATA[TRI]]></dc:subject><dc:subject><![CDATA[PDT]]></dc:subject><dc:subject><![CDATA[FDA]]></dc:subject><dc:contributor><![CDATA[SetPoint Medical]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>A New Option for Better Sleep: Joe DiMaggio Children's Hospital Expands Care for Teens With Down Syndrome</title><link>https://www.prnewswire.com/news-releases/a-new-option-for-better-sleep-joe-dimaggio-childrens-hospital-expands-care-for-teens-with-down-syndrome-302922528.html</link><guid>https://www.prnewswire.com/news-releases/a-new-option-for-better-sleep-joe-dimaggio-childrens-hospital-expands-care-for-teens-with-down-syndrome-302922528.html</guid><pubDate>Wed, 28 Oct 2026 18:00:00 +0000</pubDate><description><![CDATA[<p>Hospital to become the only center in South Florida offering Inspire® therapy for pediatric patients with Down syndrome and obstructive sleep apnea HOLLYWOOD, Fla., Oct. 28, 2026 /PRNewswire/ -- During Down Syndrome Awareness Month, Joe DiMaggio Children's Hospital is celebrating its...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS1112473/Memorial-Healthcare-System-Logo.jpg?id=OA3044712&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/a-new-option-for-better-sleep-joe-dimaggio-childrens-hospital-expands-care-for-teens-with-down-syndrome-302922528.html'><img src='https://mmx.prnewswire.com/media/MS1112473/Memorial-Healthcare-System-Logo.jpg?id=OA3044712&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:subject><![CDATA[Children]]></prn:subject><prn:subject><![CDATA[Diversity, Equity & Inclusion]]></prn:subject><dc:subject><![CDATA[CHI]]></dc:subject><dc:subject><![CDATA[DEI]]></dc:subject><dc:contributor><![CDATA[Memorial Healthcare System]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Companion Spine Announces Completion of Paradigm Spine Integration, Establishing a Unified Global Leader in Posterior Dynamic and Controlled Motion Spine Solutions</title><link>https://www.prnewswire.com/news-releases/companion-spine-announces-completion-of-paradigm-spine-integration-establishing-a-unified-global-leader-in-posterior-dynamic-and-controlled-motion-spine-solutions-302922410.html</link><guid>https://www.prnewswire.com/news-releases/companion-spine-announces-completion-of-paradigm-spine-integration-establishing-a-unified-global-leader-in-posterior-dynamic-and-controlled-motion-spine-solutions-302922410.html</guid><pubDate>Wed, 28 Oct 2026 16:09:00 +0000</pubDate><description><![CDATA[<p>Companion Spine completes the integration of Paradigm Spine, unifying its portfolio of posterior dynamic stabilization and controlled motion technologies under its SMART Solutions™ strategy to address the continuum of lumbar spinal stenosis ("LSS") and degenerative disc disease ("DDD")...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2022767/NATIVE-logo-companion-spine-with-tagline.jpg?id=OA3044917&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/companion-spine-announces-completion-of-paradigm-spine-integration-establishing-a-unified-global-leader-in-posterior-dynamic-and-controlled-motion-spine-solutions-302922410.html'><img src='https://mmx.prnewswire.com/media/MS2022767/NATIVE-logo-companion-spine-with-tagline.jpg?id=OA3044917&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Banking & Financial Services]]></prn:industry><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[FIN]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:subject><![CDATA[Acquisitions, Mergers and Takeovers]]></prn:subject><prn:subject><![CDATA[Corporate Expansion]]></prn:subject><dc:subject><![CDATA[CXP]]></dc:subject><dc:subject><![CDATA[TNM]]></dc:subject><dc:contributor><![CDATA[Companion Spine USA LLC]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Veterinary Implants Devices Market worth $0.98 billion by 2031 - Exclusive Report by MarketsandMarkets™</title><link>https://www.prnewswire.com/news-releases/veterinary-implants-devices-market-worth-0-98-billion-by-2031---exclusive-report-by-marketsandmarkets-302921974.html</link><guid>https://www.prnewswire.com/news-releases/veterinary-implants-devices-market-worth-0-98-billion-by-2031---exclusive-report-by-marketsandmarkets-302921974.html</guid><pubDate>Wed, 28 Oct 2026 14:30:00 +0000</pubDate><description><![CDATA[<p>DELRAY BEACH, Fla., Oct. 28, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Veterinary Implants Devices Market is projected to reach USD 0.98 billion by 2031 from USD 0.74 billion in 2026, at a CAGR of 5.7% during the forecast period. Browse 500 market data Tables and 51...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS1173081/MarketsandMarkets-Logo.jpg?id=OA3044150&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/veterinary-implants-devices-market-worth-0-98-billion-by-2031---exclusive-report-by-marketsandmarkets-302921974.html'><img src='https://mmx.prnewswire.com/media/MS1173081/MarketsandMarkets-Logo.jpg?id=OA3044150&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Publishing & Information Services ]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[PUB]]></prn:industry><prn:subject><![CDATA[Animals & Pets]]></prn:subject><prn:subject><![CDATA[Animal Welfare ]]></prn:subject><prn:subject><![CDATA[Market Research Reports]]></prn:subject><dc:subject><![CDATA[PET]]></dc:subject><dc:subject><![CDATA[ANW]]></dc:subject><dc:subject><![CDATA[MRR]]></dc:subject><dc:contributor><![CDATA[MarketsandMarkets]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Hearing Aids Market to Surpass USD 13 Billion by 2031 Supported by AI-Powered Audio Technology and Rising Hearing Care Needs, Says Mordor Intelligence</title><link>https://www.prnewswire.com/news-releases/hearing-aids-market-to-surpass-usd-13-billion-by-2031-supported-by-ai-powered-audio-technology-and-rising-hearing-care-needs-says-mordor-intelligence-302922151.html</link><guid>https://www.prnewswire.com/news-releases/hearing-aids-market-to-surpass-usd-13-billion-by-2031-supported-by-ai-powered-audio-technology-and-rising-hearing-care-needs-says-mordor-intelligence-302922151.html</guid><pubDate>Wed, 28 Oct 2026 14:03:00 +0000</pubDate><description><![CDATA[<p>HYDERABAD, India, Oct. 28, 2026 /PRNewswire/ -- According to the latest report by Mordor Intelligence, the hearing aids market size is estimated at USD 10.60 billion in 2026 and is projected to reach USD 13.34 billion by 2031, registering a CAGR of 4.72% during the forecast period...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS1701215/Mordor-Intelligence-Logo.jpg?id=OA3044412&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/hearing-aids-market-to-surpass-usd-13-billion-by-2031-supported-by-ai-powered-audio-technology-and-rising-hearing-care-needs-says-mordor-intelligence-302922151.html'><img src='https://mmx.prnewswire.com/media/MS1701215/Mordor-Intelligence-Logo.jpg?id=OA3044412&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:subject><![CDATA[Market Research Reports]]></prn:subject><dc:subject><![CDATA[MRR]]></dc:subject><dc:contributor><![CDATA[Mordor Intelligence Private Limited]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Infection Control Market to Grow from US$ 58.5 Bn in 2026 to US$ 80.2 Bn by 2031 at 6.5% CAGR as Hospitals Automate Reprocessing: Wissen Research</title><link>https://www.prnewswire.com/news-releases/infection-control-market-to-grow-from-us-58-5-bn-in-2026-to-us-80-2-bn-by-2031-at-6-5-cagr-as-hospitals-automate-reprocessing-wissen-research-302922251.html</link><guid>https://www.prnewswire.com/news-releases/infection-control-market-to-grow-from-us-58-5-bn-in-2026-to-us-80-2-bn-by-2031-at-6-5-cagr-as-hospitals-automate-reprocessing-wissen-research-302922251.html</guid><pubDate>Wed, 28 Oct 2026 13:54:00 +0000</pubDate><description><![CDATA[<p>SHERIDAN, Wyo., Oct. 28, 2026 /PRNewswire/ -- How big is the infection control market, and what is driving its growth? The global infection control market is valued at USD 58.5 billion in 2026 and is projected to reach USD 80.2 billion by 2031, growing at a CAGR of 6.5% over the forecast...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS1837774/Wissen-Research-Logo.jpg?id=OA3044615&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/infection-control-market-to-grow-from-us-58-5-bn-in-2026-to-us-80-2-bn-by-2031-at-6-5-cagr-as-hospitals-automate-reprocessing-wissen-research-302922251.html'><img src='https://mmx.prnewswire.com/media/MS1837774/Wissen-Research-Logo.jpg?id=OA3044615&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Infection Control]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[IDC]]></prn:industry><prn:subject><![CDATA[Market Research Reports]]></prn:subject><dc:subject><![CDATA[MRR]]></dc:subject><dc:contributor><![CDATA[Wissen Research LLC]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System</title><link>https://www.prnewswire.com/news-releases/fda-grants-breakthrough-device-designation-to-pharaoh-neuros-neurapheresis-csf-management-system-302922219.html</link><guid>https://www.prnewswire.com/news-releases/fda-grants-breakthrough-device-designation-to-pharaoh-neuros-neurapheresis-csf-management-system-302922219.html</guid><pubDate>Wed, 28 Oct 2026 13:33:00 +0000</pubDate><description><![CDATA[<p>Designation recognizes the potential of Neurapheresis to offer advantages over existing treatment options following aneurysmal subarachnoid hemorrhage (aSAH) MINNEAPOLIS, Oct. 28, 2026 /PRNewswire/ -- Pharaoh Neuro, Inc., (https://pharaohneuro.com), a medical device company developing...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2022658/Amaza-Reitmier-CEO-Pharoah-Neuro.jpg?id=OA3044594&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/fda-grants-breakthrough-device-designation-to-pharaoh-neuros-neurapheresis-csf-management-system-302922219.html'><img src='https://mmx.prnewswire.com/media/MS2022658/Amaza-Reitmier-CEO-Pharoah-Neuro.jpg?id=OA3044594&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:subject><![CDATA[FDA Approval]]></prn:subject><dc:subject><![CDATA[FDA]]></dc:subject><dc:contributor><![CDATA[Pharaoh Neuro]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>The WOCN® Society Supports Bipartisan Bill to Protect Access to Ostomy &amp; Urological Supplies</title><link>https://www.prnewswire.com/news-releases/the-wocn-society-supports-bipartisan-bill-to-protect-access-to-ostomy--urological-supplies-302921849.html</link><guid>https://www.prnewswire.com/news-releases/the-wocn-society-supports-bipartisan-bill-to-protect-access-to-ostomy--urological-supplies-302921849.html</guid><pubDate>Wed, 28 Oct 2026 13:15:00 +0000</pubDate><description><![CDATA[<p>MOUNT LAUREL TOWNSHIP, N.J., Oct. 28, 2026 /PRNewswire/ -- The Wound, Ostomy, and Continence Nurses Society™ (WOCN®) today announced its support for the Access to Medical Supplies Act, H.R. 10787, bipartisan legislation that would exclude ostomy and urological supplies from Medicare's...</p>]]></description><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:subject><![CDATA[Advocacy Group Opinion]]></prn:subject><dc:subject><![CDATA[AVO]]></dc:subject><dc:contributor><![CDATA[WOCN Society]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>HOPPR Expands Medical Imaging AI Portfolio with Whole-Body Musculoskeletal X-ray Narrative Model</title><link>https://www.prnewswire.com/news-releases/hoppr-expands-medical-imaging-ai-portfolio-with-whole-body-musculoskeletal-x-ray-narrative-model-302921827.html</link><guid>https://www.prnewswire.com/news-releases/hoppr-expands-medical-imaging-ai-portfolio-with-whole-body-musculoskeletal-x-ray-narrative-model-302921827.html</guid><pubDate>Wed, 28 Oct 2026 13:02:00 +0000</pubDate><description><![CDATA[<p>HOPPR® FS MSK Whole-Body Narrative Model generates draft report findings from up to three X-ray views per study, with customization and integration available through HOPPR Forward Deployed Services Vision-language foundation model that drafts the findings section of a musculoskeletal...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS1686241/HOPPR-logo-Logo-Logo.jpg?id=OA3043400&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/hoppr-expands-medical-imaging-ai-portfolio-with-whole-body-musculoskeletal-x-ray-narrative-model-302921827.html'><img src='https://mmx.prnewswire.com/media/MS1686241/HOPPR-logo-Logo-Logo.jpg?id=OA3043400&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><dc:contributor><![CDATA[Hoppr]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>MolecuLight Named Frost &amp; Sullivan's 2026 Global Company of the Year in Wound Imaging</title><link>https://www.prnewswire.com/news-releases/moleculight-named-frost--sullivans-2026-global-company-of-the-year-in-wound-imaging-302921291.html</link><guid>https://www.prnewswire.com/news-releases/moleculight-named-frost--sullivans-2026-global-company-of-the-year-in-wound-imaging-302921291.html</guid><pubDate>Wed, 28 Oct 2026 13:00:00 +0000</pubDate><description><![CDATA[<p>Recognition highlights FDA approvals, improved patient outcomes, clinical evidence, integrated wound imaging, and commitment to customer support PITTSBURGH, Oct. 28, 2026 /PRNewswire/ -- Today, MolecuLight announces that it has received Frost & Sullivan's 2026 Global Company of the Year...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2022022/MolecuLight-MolecuLight-Named-Frost-Sullivan-s-2026-Global-Com.jpg?id=OA3043291&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/moleculight-named-frost--sullivans-2026-global-company-of-the-year-in-wound-imaging-302921291.html'><img src='https://mmx.prnewswire.com/media/MS2022022/MolecuLight-MolecuLight-Named-Frost-Sullivan-s-2026-Global-Com.jpg?id=OA3043291&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:subject><![CDATA[Awards]]></prn:subject><dc:subject><![CDATA[AWD]]></dc:subject><dc:contributor><![CDATA[MolecuLight Inc.]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>MolecuLight nommée entreprise mondiale de l'année 2026 par Frost &amp; Sullivan dans le domaine de l'imagerie des plaies</title><link>https://www.prnewswire.com/news-releases/moleculight-nommee-entreprise-mondiale-de-lannee-2026-par-frost--sullivan-dans-le-domaine-de-limagerie-des-plaies-302921677.html</link><guid>https://www.prnewswire.com/news-releases/moleculight-nommee-entreprise-mondiale-de-lannee-2026-par-frost--sullivan-dans-le-domaine-de-limagerie-des-plaies-302921677.html</guid><pubDate>Wed, 28 Oct 2026 13:00:00 +0000</pubDate><description><![CDATA[<p>Cette reconnaissance souligne les approbations de la FDA, l'amélioration des résultats pour les patients, les preuves cliniques, l'imagerie intégrée des plaies et l'engagement envers le soutien à la clientèle. PITTSBURGH, 28 octobre 2026 /PRNewswire/ -- Aujourd'hui, MolecuLight annonce...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2022022/MolecuLight-MolecuLight-nommée-entreprise-mondiale-de-l-année-20.jpg?id=OA3043294&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/moleculight-nommee-entreprise-mondiale-de-lannee-2026-par-frost--sullivan-dans-le-domaine-de-limagerie-des-plaies-302921677.html'><img src='https://mmx.prnewswire.com/media/MS2022022/MolecuLight-MolecuLight-nommée-entreprise-mondiale-de-l-année-20.jpg?id=OA3043294&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:subject><![CDATA[Awards]]></prn:subject><dc:subject><![CDATA[AWD]]></dc:subject><dc:contributor><![CDATA[MolecuLight Inc.]]></dc:contributor><dc:language>fr</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>MolecuLight wurde von Frost &amp; Sullivan zur 2026 Global Company of the Year im Bereich Wound Imaging ernannt</title><link>https://www.prnewswire.com/news-releases/moleculight-wurde-von-frost--sullivan-zur-2026-global-company-of-the-year-im-bereich-wound-imaging-ernannt-302921673.html</link><guid>https://www.prnewswire.com/news-releases/moleculight-wurde-von-frost--sullivan-zur-2026-global-company-of-the-year-im-bereich-wound-imaging-ernannt-302921673.html</guid><pubDate>Wed, 28 Oct 2026 13:00:00 +0000</pubDate><description><![CDATA[<p>Die Auszeichnung würdigt FDA-Zulassungen, verbesserte Patientenergebnisse, klinische Evidenz, integrierte Wundbildgebung und das Engagement für den Kundenservice PITTSBURGH, 28. Oktober 2026 /PRNewswire/ -- Heute gibt MolecuLight bekannt, dass es den Frost & Sullivan 2026 Global Company...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2022022/MolecuLight-MolecuLight-wurde-von-Frost-Sullivan-zur-2026-Glob.jpg?id=OA3043296&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/moleculight-wurde-von-frost--sullivan-zur-2026-global-company-of-the-year-im-bereich-wound-imaging-ernannt-302921673.html'><img src='https://mmx.prnewswire.com/media/MS2022022/MolecuLight-MolecuLight-wurde-von-Frost-Sullivan-zur-2026-Glob.jpg?id=OA3043296&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:subject><![CDATA[Awards]]></prn:subject><dc:subject><![CDATA[AWD]]></dc:subject><dc:contributor><![CDATA[MolecuLight Inc.]]></dc:contributor><dc:language>de</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>MolecuLight, nombrada «Empresa global del año 2026» por Frost &amp; Sullivan en imagenología de heridas</title><link>https://www.prnewswire.com/news-releases/moleculight-nombrada-empresa-global-del-ano-2026-por-frost--sullivan-en-imagenologia-de-heridas-302922088.html</link><guid>https://www.prnewswire.com/news-releases/moleculight-nombrada-empresa-global-del-ano-2026-por-frost--sullivan-en-imagenologia-de-heridas-302922088.html</guid><pubDate>Wed, 28 Oct 2026 13:00:00 +0000</pubDate><description><![CDATA[<p>Este reconocimiento destaca las aprobaciones de la FDA, la mejora en los resultados de los pacientes, la evidencia clínica, la integración de imágenes de heridas y el compromiso con la atención al cliente PITTSBURGH, 28 de octubre de 2026 /PRNewswire/ -- MolecuLight ha anunciado hoy la...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2022022/MolecuLight-MolecuLight-nombrada-Empresa-global-del-año-2026.jpg?id=OA3043298&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/moleculight-nombrada-empresa-global-del-ano-2026-por-frost--sullivan-en-imagenologia-de-heridas-302922088.html'><img src='https://mmx.prnewswire.com/media/MS2022022/MolecuLight-MolecuLight-nombrada-Empresa-global-del-año-2026.jpg?id=OA3043298&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:subject><![CDATA[Awards]]></prn:subject><dc:subject><![CDATA[AWD]]></dc:subject><dc:contributor><![CDATA[MolecuLight Inc.]]></dc:contributor><dc:language>es</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Virtualitics Names Sports Medicine Expert Dr. Bert Mandelbaum as Scientific Advisor</title><link>https://www.prnewswire.com/news-releases/virtualitics-names-sports-medicine-expert-dr-bert-mandelbaum-as-scientific-advisor-302921376.html</link><guid>https://www.prnewswire.com/news-releases/virtualitics-names-sports-medicine-expert-dr-bert-mandelbaum-as-scientific-advisor-302921376.html</guid><pubDate>Wed, 28 Oct 2026 13:00:00 +0000</pubDate><description><![CDATA[<p>World-renowned orthopedic surgeon and sports medicine expert brings decades of experience in injury prevention, workforce health, and performance readiness to strengthen Virtualitics' medical readiness initiatives. Virtualitics has appointed world-renowned orthopedic surgeon and sports...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS1783934/Virtualitics-Logo-Gradient-Logo.jpg?id=OA3042292&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/virtualitics-names-sports-medicine-expert-dr-bert-mandelbaum-as-scientific-advisor-302921376.html'><img src='https://mmx.prnewswire.com/media/MS1783934/Virtualitics-Logo-Gradient-Logo.jpg?id=OA3042292&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Computer & Electronics]]></prn:industry><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[General Sports]]></prn:industry><prn:industry><![CDATA[Artificial Intelligence]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[CPR]]></prn:industry><prn:industry><![CDATA[AFI]]></prn:industry><prn:industry><![CDATA[SPT]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:subject><![CDATA[Personnel Announcements ]]></prn:subject><dc:subject><![CDATA[PER]]></dc:subject><dc:contributor><![CDATA[Virtualitics]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Appian and PSI CRO Form Strategic Partnership to Advance AI-driven Clinical Trial Operations</title><link>https://www.prnewswire.com/news-releases/appian-and-psi-cro-form-strategic-partnership-to-advance-ai-driven-clinical-trial-operations-302921763.html</link><guid>https://www.prnewswire.com/news-releases/appian-and-psi-cro-form-strategic-partnership-to-advance-ai-driven-clinical-trial-operations-302921763.html</guid><pubDate>Wed, 28 Oct 2026 13:00:00 +0000</pubDate><description><![CDATA[<p>First joint project launches a broader platform strategy for process orchestration across the clinical trial lifecycle BERLIN, Oct. 28, 2026 /PRNewswire/ -- Appian [Nasdaq: APPN] and PSI CRO announced today the launch of their first joint AI-powered process orchestration solution. The new...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2022318/AdobeStock_443627739.jpg?id=OA3043713&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/appian-and-psi-cro-form-strategic-partnership-to-advance-ai-driven-clinical-trial-operations-302921763.html'><img src='https://mmx.prnewswire.com/media/MS2022318/AdobeStock_443627739.jpg?id=OA3043713&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Computer & Electronics]]></prn:industry><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[Artificial Intelligence]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[CPR]]></prn:industry><prn:industry><![CDATA[AFI]]></prn:industry><prn:subject><![CDATA[Licensing ]]></prn:subject><prn:subject><![CDATA[Clinical Trials & Medical Discoveries]]></prn:subject><dc:subject><![CDATA[TRI]]></dc:subject><dc:subject><![CDATA[LIC]]></dc:subject><dc:contributor><![CDATA[Appian]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>MolecuLight Named Frost &amp; Sullivan's 2026 Global Company of the Year in Wound Imaging</title><link>https://www.prnewswire.com/news-releases/moleculight-named-frost--sullivans-2026-global-company-of-the-year-in-wound-imaging-302921743.html</link><guid>https://www.prnewswire.com/news-releases/moleculight-named-frost--sullivans-2026-global-company-of-the-year-in-wound-imaging-302921743.html</guid><pubDate>Wed, 28 Oct 2026 13:00:00 +0000</pubDate><description><![CDATA[<p>Recognition highlights FDA approvals, improved patient outcomes, clinical evidence, integrated wound imaging, and commitment to customer support PITTSBURGH, Oct. 28, 2026 /PRNewswire/ -- Today, MolecuLight announces that it has received Frost & Sullivan's 2026 Global Company of the Year...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2022004/MolecuLight-MolecuLight-Named-Frost-Sullivan-s-2026-Global-Com.jpg?id=OA3042850&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/moleculight-named-frost--sullivans-2026-global-company-of-the-year-in-wound-imaging-302921743.html'><img src='https://mmx.prnewswire.com/media/MS2022004/MolecuLight-MolecuLight-Named-Frost-Sullivan-s-2026-Global-Com.jpg?id=OA3042850&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:subject><![CDATA[Awards]]></prn:subject><dc:subject><![CDATA[AWD]]></dc:subject><dc:contributor><![CDATA[MolecuLight]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Clarius Leads Handheld Ultrasound AI with Industry's Largest Integrated Portfolio of 30 Models</title><link>https://www.prnewswire.com/news-releases/clarius-leads-handheld-ultrasound-ai-with-industrys-largest-integrated-portfolio-of-30-models-302921773.html</link><guid>https://www.prnewswire.com/news-releases/clarius-leads-handheld-ultrasound-ai-with-industrys-largest-integrated-portfolio-of-30-models-302921773.html</guid><pubDate>Wed, 28 Oct 2026 12:40:00 +0000</pubDate><description><![CDATA[<p>Proprietary AI development engine turns clinical ideas into working models in weeks, accelerating the next generation of intelligent point-of-care ultrasound. VANCOUVER, BC, Oct. 28, 2026 /PRNewswire/ -- Clarius Mobile Health is raising the bar for artificial intelligence in handheld...</p>]]></description><media:content url="https://www.youtube.com/watch?v=usDAI6G4LnQ" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/clarius-leads-handheld-ultrasound-ai-with-industrys-largest-integrated-portfolio-of-30-models-302921773.html'><img src='https://www.youtube.com/watch?v=usDAI6G4LnQ' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[Medical Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[Pharmaceuticals]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:industry><![CDATA[MTC]]></prn:industry><prn:industry><![CDATA[PHA]]></prn:industry><prn:subject><![CDATA[FDA Approval]]></prn:subject><prn:subject><![CDATA[Broadcast Feed Annoucement]]></prn:subject><prn:subject><![CDATA[International Medical Approval]]></prn:subject><dc:subject><![CDATA[BFA]]></dc:subject><dc:subject><![CDATA[FDA]]></dc:subject><dc:subject><![CDATA[IMA]]></dc:subject><dc:contributor><![CDATA[Clarius Mobile Health]]></dc:contributor><dc:language>en-US</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item><item><title>Hodinky HUAWEI WATCH D3 debutujú na konferencii ISH-ECS 2026 a prinášajú pokročilé monitorovanie krvného tlaku do bežného života</title><link>https://www.prnewswire.com/news-releases/hodinky-huawei-watch-d3-debutuju-na-konferencii-ish-ecs-2026-a-prinaaju-pokroile-monitorovanie-krvneho-tlaku-do-beneho-ivota-302922105.html</link><guid>https://www.prnewswire.com/news-releases/hodinky-huawei-watch-d3-debutuju-na-konferencii-ish-ecs-2026-a-prinaaju-pokroile-monitorovanie-krvneho-tlaku-do-beneho-ivota-302922105.html</guid><pubDate>Wed, 28 Oct 2026 12:01:00 +0000</pubDate><description><![CDATA[<p>DUBAJ, SAE, 28. októbra 2026 /PRNewswire/ -- V Dubaji sa od 22. do 25. októbra 2026 konalo 31. vedecké stretnutie Medzinárodnej spoločnosti pre hypertenziu (International Society of Hypertension, ISH) a 17. výročná konferencia Emirátskej kardiologickej spoločnosti (Emirates Cardiac...</p>]]></description><media:content url="https://mmx.prnewswire.com/media/MS2020534/20261026073851EDT_image_1.jpg?id=OA3041233&amp;p=original" type="image/jpeg" width="144"><media:text type="html"><![CDATA[<p><a href='https://www.prnewswire.com/news-releases/hodinky-huawei-watch-d3-debutuju-na-konferencii-ish-ecs-2026-a-prinaaju-pokroile-monitorovanie-krvneho-tlaku-do-beneho-ivota-302922105.html'><img src='https://mmx.prnewswire.com/media/MS2020534/20261026073851EDT_image_1.jpg?id=OA3041233&p=original' align='left'  width='144' alt='photo' title='' border='0'/><a></p><br clear='all'/>]]></media:text><media:credit role="publishing company">PRNewswire</media:credit></media:content><prn:industry><![CDATA[Health Care & Hospitals]]></prn:industry><prn:industry><![CDATA[Medical Equipment]]></prn:industry><prn:industry><![CDATA[HEA]]></prn:industry><prn:industry><![CDATA[MEQ]]></prn:industry><prn:subject><![CDATA[New Products & Services ]]></prn:subject><prn:subject><![CDATA[Surveys, Polls and Research ]]></prn:subject><dc:subject><![CDATA[SVY]]></dc:subject><dc:subject><![CDATA[PDT]]></dc:subject><dc:contributor><![CDATA[Huawei]]></dc:contributor><dc:language>sk</dc:language><dc:publisher>PR Newswire Association LLC.</dc:publisher></item></channel></rss>